Case Report
Accepted on 31 Jul 2025
Pembrolizumab Combined with Lenvatinib and Metronomic Cyclophosphamide in Platinum-Resistant Ovarian Cancer: A Case Report of Durable Clinical Response
in Gynecological Oncology
- 107 views
Case Report
Accepted on 31 Jul 2025
in Gynecological Oncology
Original Research
Accepted on 31 Jul 2025
in Healthy Longevity
Opinion
Accepted on 31 Jul 2025
in Water and Wastewater Management
Case Report
Accepted on 31 Jul 2025
in Pulmonary Medicine
Review
Accepted on 31 Jul 2025
in Soil Processes
Original Research
Accepted on 31 Jul 2025
in Interdisciplinary Climate Studies
Original Research
Accepted on 31 Jul 2025
in T Cell Biology
Original Research
Accepted on 31 Jul 2025
in Quantitative Psychology and Measurement
Original Research
Accepted on 31 Jul 2025
in Agricultural and Food Economics
Original Research
Accepted on 31 Jul 2025
in Cancer Imaging and Image-directed Interventions
Systematic Review
Accepted on 31 Jul 2025
in Sport and Exercise Nutrition
Case Report
Accepted on 31 Jul 2025
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Original Research
Accepted on 31 Jul 2025
in Virology
Original Research
Accepted on 31 Jul 2025
in Viral Immunology
Original Research
Accepted on 31 Jul 2025
in Culture and Communication
Case Report
Accepted on 31 Jul 2025
in ADHD